Resumen
Around 10?12% of patients present with oligometastatic disease (OMD) from oesophageal or gastric cancer (OGC). Potential curative treatment is debated in these patients, especially when located in the liver. The aim of this study was to describe the outcomes of patients who underwent surgical treatment of the primary tumour together with local treatment of synchronous liver metastases. We report a 5-year survival of 30%, but disease recurred in 80% of patients. Patients with a solitary liver metastasis may have the best prognosis, but more data are needed to optimise patient selection for curative treatment.